Pathologic Effects of Butylated Triphenyl Phosphate-Based Hydraulic Fluid and Tricresyl Phosphate on the Adrenal Gland,Ovary,and Testis in the Fischer-344 Rat

Abstract

Triaryl phosphates including tricresyl phosphate (TCP) and butylated triphenyl phosphates (BTPs) are used in the commercial manufacture of plastics, lubricants, and hydraulic fluids. Recent reports implicate these compounds as endocrine and reproductive toxicants in rodents. The objectives of this study were to develop and characterize a rat model to investigate the mechanism(s) of toxicity of triaryl phosphate-based hydraulic fluids and to elucidate potential mechanistic pathways of toxicity through studies of structural/ functional relationships. Groups of male and female rats received daily oral doses of either sesame oil alone or 1.7 g/kg of BTP or 0.4 g/kg TCP in sesame oil vehicle or 2.8 g/kg neat BTP for 20, 40, and 60 days. Light microscopic, morphometric, ultrastructural, and histochemical studies revealed hypertrophy and cholesteryl lipidosis of adrenocortical (both sexes) and ovarian interstitial cells that were progressive with duration of exposure. Minimal degeneration was observed in the adrenal cortex and ovary. TCP caused the most severe lesions in both the adrenal gland and ovary, but the morphologic and histochemical changes produced were similar for both compounds, suggesting a common mechanism of toxicity. Decreased testicular weight and degeneration of seminiferous tubules were detected only in TCP-treated rats. The Fischer-344 rat model using TCP and BTP administered by gavage is a valuable system to study mechanisms of endocrine and reproductive toxicity induced by triaryl phosphate-based hydraulic fluids.

Keywords

Cholesteryl lipidosis adrenocortical cell ovarian interstitial cell degeneration seminiferous tubule

References

Abou-Donia MB (1981). Organophosphorus ester-induced delayed neuratoxicity. Annu. Rev. Pharmacol. Toxicol. 21: 511-548.

Bondy HF Field EJ Worden AN and Hughes JPW (1960). A study on the acute toxicity of the tri-aryl phosphates used as plasticizers. Brit. J. Industr. Med. 17:190-200.

Carlton BD , Barlett PB , and Smith MK (1986). Reproductive toxicity of tricresyl phosphate in Long Evans rats. Toxicology 6: 292.

Carlton BD , Basaran AH Mezza LE , and Smith MK (1987). Examination of the reproductive effects of tricresyl phosphate administered to Long-Evans rats. Toxicology 46: 32 1-328.

Carlton BD Irwin R. Hejtmancik M. Deskin R. Ryan M. and Peters AC (1986). Reproductive toxicity of tricresyl phosphate in male rats and mice by two dosing routes. Texicologist 6: 292.

Chamacho AM , Cash R. Brough AJ , and Wilroy RS (1967). Inhibition of adrenal steroidogenesis by aminoglutethimide and the mechanism of action. J. Am. Vet. Med. Assoc. 202: 114-120.

Chapin RE George JD and Lamb JC IV (1988). Reproductive toxicity of tricresyl phosphate in a continuous breeding protocol in Swiss (cd-1) mice. Fund. Appl. Toxicol. 10: 344-354.

Chapin RE Phelps JL , Burka LT Abou-Donia MB and Heindel JJ (1991). The effects of tri-o-cresyl phosphate and metabolites on rat Sertoli cell function in primary culture. Toxicol. Appl. Pharmacel. 108: 194-204.

Chapin RE Phelps JL Somkuti SG Heindel JJ and Burka LT (1990). The interaction of Sertoli and Leydig cells in the testicular toxicity of tri-o-cresyl phosphate. Toxicol. Appl. Pharmacol. 104: 483-495.

10.

Cohen MP (1968). Aminoglutethimide inhibition of adrenal desmolase activity. Proc. Soc. Exp. Biol. Med. 127: 1086-1090.

11.

Colby HD (1981). Chemical suppression of steroidogenesis. Environ. Health Perspect. 38: 119-127.

12.

Dexter RN Rishman LM , Ney RL , and Liddle GW (1967). Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: Studies of the mechanism of action. J. Clin. Endocrinol. 27: 473-480.

13.

Environmental Protection Agency (1983). Aryl phosphates; response to the interagency testing committee. Fed. Reg. 48: 57452-57460.

14.

Erickson GF (1987). The ovary: Basic principles and concepts. In: Endocrinology and Metabolism, 2nd ed., P Felig , JD Baxter , AE Broadus , LA Frohman (eds). McGraw-Hill, New York, pp. 905-950.

15.

Erickson GF , Magoffen D. , Dyer CA , and Hofeditz C. (1985). The ovarian androgen producing cells: A review of structure/function relationships . Endocrinol. Rev. 6: 371-399.

16.

Eto M. (1974). Organophosphorus Pesticides: Organic and Biological Chemistry. CRC Press, Cleveland, Ohio.

17.

Hejtmancik M. , Deskin R. , Ryan M. , Carlton B. , Haggerty G. , Peters A. , and Irwin R. (1986). Comparative dosed feed and gavage subchronic studies of tricresyl phosphate (TCP) in F344 rats and B6C3F1 mice. Toxicologist 6 : 207.

18.

Hertz R. , Tullner WW , Schricker JA , Dhyse FG , and Hallman LF (1955). Studies on amphenone and related compounds. Rec. Prog. Horm. Res. 11: 119-147.

19.

Hollingshaus GJ (1984). Chemistry and metabolism of delayed neurotoxic organophosphorus esters. Proc. 14th Ann. Conf. Environ. Toxicol. Wright-Patterson AFB, Air Force Aerospace Medical Research Laboratory Technical Report 83-099, p. 76.

20.

Kovacs K. , Bloscheck JA , Yeghiayan E. , Hatakeyame S. , and Gardell C. (1971). Adrenocortical lipid hyperplasia induced in rats by aniline: A histologic and electron microscopic study. Am. J. Pathol. 62: 17-34.

21.

Lamb JC IV (1985). Reproductive toxicity testing: Evaluating and developing new testing systems. J. Am. Coll. Toxicol. 4: 163-171.

22.

Latendresse JR , Azhar S. , Brooks CL , and Capen CC (1993). Pathogenesis of cholesteryl lipidosis of adrenocortical and ovarian interstitial cells in F344 rats caused by tricresyl phosphate and butylated triphenyl phosphate . Toxieol. Appl. Pharmacol. 122: 281-289.

23.

Latendresse JR , Brooks CL , and Capen CC (1994). Reproductive toxicity of butylated triphenyl phosphate and tricresyl phosphate fluids in F344 rats . Fund. Appl. Toxicol. 22: 392-399.

24.

Latendresse JR , Brooks CL , and Capen CC (1994). Toxic effects of butylated triphenyl phosphate-based hydraulic fluid and tricresyl phosphate in female F344 rats. Vet. Pathol. (in press).

25.

Luse S. ( 1967). Fine structure of the adrenal cortex. In: The Adrenal Cortex, AB Esenstein (ed). Little, Brown and Co., Boston, pp. 1-69.

26.

Malendowicz LK (1972). Steatotic degeneration ofrat adrenocortical cells after treatment with aminoglutethemide. Acta Histochem. (Jena) 43: 350-360.

27.

Maronpot RR (1987). Ovarian toxicity and carcinogenicity in eight recent national toxicology program studies. Environ. Health Perspect. 73: 125-130.

28.

Payne AH , Quinn PG , and Stalvey JRD (1985). The stimulation of steroid biosynthesis by luteinizing hormone. In: Luteinizing Hormone Action and Receptors, M Ascoli (ed). CRC Press, Boca Raton, Florida, pp. 136-173.

29.

Racela A. Jr , Azarnoff D. , and Svoboda D. (1969). Mitochondrial cavitation and hypertrophy in rat adrenal cortex due to aminoglutethemide . Lab. Invest. 21: 52-60.

30.

Rossi GL and Bestetti G. (1983). Technical aspects in the study of pathologic lesions in the hypothalamus of the rat. In: Endocrine System, TC Jones , U Mohr , and RD Hunt (eds). Springer-Verlag, New York, pp. 308-316.

31.

Sheehan DC and Hrapchak BB (1980). Digitonin reaction. In: Theory and Practice of Histotechnology, 2nd ed. CV Mosby Company, St. Louis, Missouri, pp. 212-213.

32.

Smith MI , Elvove E. , and Frazier WH (1930). The pharmacological actions of certain phenol esters with specific reference to the etiology of so-called ginger paralysis . Pub. Health Rep. 45: 2509-2524.

33.

Somkuti SG , Lapadula DM , Chapin RE , and Abou-Donia MB (1991). Light and electron microscopic evidence of tri-o-cresyl phosphate (TOCP)-mediated testicular toxicity in Fischer 344 rats. Toxacol. Appl. Pharmacol. 107: 35-46.

34.

Temple TE and Liddle GW (1970). Inhibitors of adrenal steroid biosynthesis. Annu. Rev. Pharmacol. 10: 199-218.

35.

Wall HG , Kinkead ER , Vinegar A. , Bruner RH , and Flemming CD (1990). Pathologic Effects in Animals after Subchronic Inhalation Exposure to MIL-H-19457C, MIL-H-19457B, or MIL-H-22072B. Toxic Hazards Research Unit Annual Technical Report. AAMRL-TR-90-063. Armstrong Aerospace Medical Research Laboratory, Wright-Patterson AFB, Ohio 45433-6573, pp. 306-322.